Not Tagged
Not Tagged
['lcsm,(-blcsm)']
do pts with kras+ tumors respond better to chemo-immuno or immuno alone, vs wildtype kras tumors? new analysis from suggests no. though chemo-immuno may be slightly better for kras+ tumors. not clear from analysis whether co-mutations matter #lcsm #asco22 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.